Aprotinin Does Not Increase the Risk of Renal Failure in Cardiac Surgery Patients

P. Furnary, Anthony; Wu, YingXing; F. Hiratzka, Loren; L. Grunkemeier, Gary; Scott Page, U.

doi:10.1161/circulationaha.106.681395

Public

Aprotinin Does Not Increase the Risk of Renal Failure in Cardiac Surgery Patients

Published in Circulation • Sep 10, 2007

Authors:

Anthony P. Furnary

YingXing Wu

Loren F. Hiratzka

Abstract

BACKGROUND: Aprotinin is frequently used in high-risk cardiac surgery patients to decrease bleeding complications and transfusions of packed red blood cells (PRBC). Transfusions of PRBC are known to directly increase the risk of new onset postoperative renal failure (ARF) in cardiac surgery patients...

Subject

Medicine

Aprotinin

Perioperative

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!